Followers

Toyota India crosses 2 million sales milestone

0
Toyota Glanza front quarter

Japanese auto giant Toyota has just crossed the two million (20 lakh) sales milestone in India. The company has achieved the milestone nearly 23 years since it first started production here.

  • Production started in December 1999
  • Currently has 419 touchpoints across India
  • New Creta-rivalling midsize SUV in the works

Toyota India 2 million sales milestone

Toyota began its India operations in October 1997, in partnership with Kirloskar Systems Limited, by setting up a manufacturing facility in Bidadi, near Bengaluru. Production started in December 1999, with the Qualis MPV being the first model.

The two millionth car to be sold was a Glanza which was delivered to the customer from its dealership in Trichur, Kerala.

Speaking about the milestone, Atul Sood, associate vice president, Sales and Strategic Marketing, Toyota India, said, “Over the last two decades, Toyota has developed a solid foundation of renowned quality, durability and reliability and we hope we will be able to cater to more segments as well as newer markets in 2022 and beyond.”

Presently, Toyota has two manufacturing plants set up in India, both at Bidadi, with a combined capacity of 3,10,000 units per year. In terms of touchpoints, the company currently has 419 dealerships and service centres spread across the country.

Earlier this year, Toyota’s rebadged Maruti models, the Glanza and Urban Cruiser, crossed the 1 lakh sales milestone. Toyota India’s current model portfolio includes the Glanza hatchback, the Urban Cruiser compact SUV, the Innova Crysta MPV, the Fortuner SUV, the Camry sedan, the Vellfire luxury MPV and the recently launched Hilux pickup.

Going forward, Toyota will soon launch the updated Urban Cruiser and a new Creta-rivalling midsize SUV which is being co-developed with Maruti Suzuki.

Also See:

Toyota Kirloskar Motor completes 20 years in India

2022 Toyota Camry Hybrid: 5 things to know



https://ift.tt/zx6FPgL

Post a Comment

0Comments
Post a Comment (0)
To Top